DEA schedule
Is repaglinide a controlled substance?
Federal schedule for repaglinide from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Repaglinide is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and repaglinide is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted repaglinide?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 20 prescription listings from 7 labelers, none with a DEA schedule |
| DEA controlled substances list | repaglinide is not on the list |
Repaglinide NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 33342-248 | Repaglinide | tablet | .5 mg/1 | Macleods Pharmaceuticals Limited | None |
| 57237-157 | Repaglinide | tablet | .5 mg/1 | Rising Pharma Holdings, Inc. | None |
| 62135-946 | Repaglinide | tablet | .5 mg/1 | Chartwell RX, LLC | None |
| 63629-4866 | Repaglinide | tablet | .5 mg/1 | Bryant Ranch Prepack | None |
| 65862-670 | Repaglinide | tablet | .5 mg/1 | Aurobindo Pharma Limited | None |
| 71335-2554 | Repaglinide | tablet | .5 mg/1 | Bryant Ranch Prepack | None |
| 72603-810 | Repaglinide | tablet | .5 mg/1 | NorthStar RxLLC | None |
| 33342-249 | Repaglinide | tablet | 1 mg/1 | Macleods Pharmaceuticals Limited | None |
| 57237-158 | Repaglinide | tablet | 1 mg/1 | Rising Pharma Holdings, Inc. | None |
| 60687-560 | Repaglinide | tablet | 1 mg/1 | American Health Packaging | None |
| 62135-947 | Repaglinide | tablet | 1 mg/1 | Chartwell RX, LLC | None |
| 65862-671 | Repaglinide | tablet | 1 mg/1 | Aurobindo Pharma Limited | None |
| 72162-2558 | Repaglinide | tablet | 1 mg/1 | Bryant Ranch Prepack | None |
| 72603-811 | Repaglinide | tablet | 1 mg/1 | NorthStar RxLLC | None |
| 33342-250 | Repaglinide | tablet | 2 mg/1 | Macleods Pharmaceuticals Limited | None |
| 57237-159 | Repaglinide | tablet | 2 mg/1 | Rising Pharma Holdings, Inc. | None |
| 62135-948 | Repaglinide | tablet | 2 mg/1 | Chartwell RX, LLC | None |
| 65862-672 | Repaglinide | tablet | 2 mg/1 | Aurobindo Pharma Limited | None |
| 71335-2598 | Repaglinide | tablet | 2 mg/1 | Bryant Ranch Prepack | None |
| 72603-812 | Repaglinide | tablet | 2 mg/1 | NorthStar RxLLC | None |
Questions
Is repaglinide a controlled substance?
No. Repaglinide is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and repaglinide is not on the DEA controlled substances list.
Is repaglinide a narcotic?
No. Repaglinide is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Glinide.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.